Nordhealth AS: Results of Share Buy Back
Nordhealth AS: Results of Share Buy Back
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES,
CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR
RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.
Helsinki, Finland, 2 July 2025: Reference is made to the stock exchange
announcement on 26 June 2025, where Nordhealth AS (the "Company") launched an
offer to purchase up to 300,000 of its own shares through a reverse book
building process (the "Offering").
The application period expired at 16:30 hours (CEST) on 2 July 2025. Following
the end of the application period, the Company has resolved to buy 300,000
shares at a price of NOK 36 per share, which equals approximately NOK 11 million
in total.
All offers to sell shares with limits at or below NOK 36 have been allocated in
full. Allocation notifications will be sent to shareholders having tendered
shares in the Offering on or about 3 July 2025. The trade date is expected to be
on or about 3 July 2025 and the settlement date is expected to be on or about 7
July 2025.
The settlement will be conducted on a normal delivery-versus-payment basis
(DVP). Following settlement of the Offering, the Company will own 1,377,793
shares in the Company. The Company currently has 80.191.746 issued shares, where
1,077,793 are held in treasury and 79,113,953 are outstanding.
For further information, please contact:
DNB Carnegie, [email protected], +47 24 16 90 20
Charles MacBain, CEO, [email protected], +44 75 3903 2200
Alexander Cram, CFO, [email protected], +32 470 69 30 20
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 60,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with 400 employees working
either remotely or from offices (collaboration hubs). Visit the Company's
website at nordhealth.com (http://www.nordhealth.com).
IMPORTANT NOTICE
The Offering and the distribution of this announcement and other information in
connection with the Offering may be restricted by law in certain jurisdictions
(including, but not limited to, the United States, Canada, Australia and Japan).
Neither the Company nor the bookrunner in the Offering assume any responsibility
in the event there is a violation by any person of such restrictions. This
includes shareholders who have changed their domicile to such jurisdictions but
which may access their VPS accounts. Persons into whose possession this
announcement or relevant information should come are required to inform
themselves about and to observe any such restrictions. The Offering is not being
made directly or indirectly in, or by use of the mails of, or by any means or
instrumentality of interstate or foreign commerce of, or any facilities of a
national securities exchange of, the United States of America, its territories
and possessions, any State of the United States and the District of Columbia
(the "United States") or any other jurisdiction in which this would be unlawful,
require registration or other measures. This includes, but is not limited to,
facsimile transmission, internet delivery, e-mail and telephones. Copies of this
release and any related documents are not being, and must not be, mailed, e
-mailed or otherwise distributed or sent in or into the United States or any
such jurisdiction and so doing may invalidate any purported acceptance.